14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
NEWTI vs BHFAL: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, NewtekOne, Inc. 8.00% Fixed Rate Senior Notes due 2028 (NEWTI) captures the overall head-to-head institutional edge over Brighthouse Financial, Inc. 6.25% Junior Subordinated Debentures due 2058 (BHFAL) on higher Unified Composite conviction (51.8/100 HOLD vs. 52.5/100 HOLD) after splitting the core matrix 2–2 (led by composite factor balance), while BHFAL wins 1–0 across the 6-pillar growth and valuation breakdown. NEWTI trades at $25.24 (N/M Forward P/E, 0.0% operating margin) versus BHFAL at $14.61 (N/M Forward P/E, 0.0% operating margin).
Composite vs. Pillar Nuance: While BHFAL currently prints a higher short-term Unified Composite Score (52.5/100 HOLD vs. NEWTI 51.8/100 HOLD), NEWTI captures the overall institutional head-to-head verdict (2–2 matrix metrics and 0–1 across the 6 pillars) due to superior fundamental profitability (0.0% vs. 0.0% operating margin) and revenue trajectory (+0.0% vs. +0.0% YoY).
Technical & Structure Timing Caution: NEWTI trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 51.2); meanwhile BHFAL is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 41.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NEWTI vs BHFAL. Trailing 12-month operating profitability (NEWTI 0.0% vs BHFAL 0.0%) and valuation multiples (NEWTI N/M vs BHFAL N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Other value chain with $3.4B market capitalization and 0.0% operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ NEWTI vs BHFAL Key Questions & Quantitative Answers
As of Nov 20, 2026, NewtekOne, Inc. 8.00% Fixed Rate Senior Notes due 2028 (NEWTI) captures the overall head-to-head institutional edge over Brighthouse Financial, Inc. 6.25% Junior Subordinated Debentures due 2058 (BHFAL) on higher Unified Composite conviction (51.8/100 HOLD vs. 52.5/100 HOLD) after splitting the core matrix 2–2 (led by composite factor balance), while BHFAL wins 1–0 across the 6-pillar growth and valuation breakdown. NEWTI trades at $25.24 (N/M Forward P/E, 0.0% operating margin) versus BHFAL at $14.61 (N/M Forward P/E, 0.0% operating margin). Composite vs. Pillar Nuance: While BHFAL currently prints a higher short-term Unified Composite Score (52.5/100 HOLD vs. NEWTI 51.8/100 HOLD), NEWTI captures the overall institutional head-to-head verdict (2–2 matrix metrics and 0–1 across the 6 pillars) due to superior fundamental profitability (0.0% vs. 0.0% operating margin) and revenue trajectory (+0.0% vs. +0.0% YoY). Technical & Structure Timing Caution: NEWTI trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 51.2); meanwhile BHFAL is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 41.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
BHFAL leads the Growth & Scale pillar: NEWTI posts +0.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin), compared with BHFAL at +0.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin). On trailing 12-month operating scale, NEWTI generates N/A in USD-normalized revenue versus N/A for BHFAL. In operating R&D and SG&A reinvestment, NEWTI deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for BHFAL.
NEWTI and BHFAL trade at balanced relative valuation multiples. NEWTI trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas BHFAL trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against NEWTI (0.0% ROE) versus BHFAL (0.0% ROE) capital efficiency.
In options market volatility and institutional positioning, NEWTI carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.04β · 6% Vol realized risk). By comparison, BHFAL carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.15β · 22% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.